| Pathophysiology of L-dopa-induced motor and non-motor complications in Parkinson's disease MF Bastide, WG Meissner, B Picconi, S Fasano, PO Fernagut, M Feyder, ... Progress in neurobiology 132, 96-168, 2015 | 533 | 2015 |
| Lack of additive role of ageing in nigrostriatal neurodegeneration triggered by α-synuclein overexpression M Bourdenx, S Dovero, M Engeln, S Bido, MF Bastide, N Dutheil, ... Acta neuropathologica communications 3, 1-15, 2015 | 136 | 2015 |
| Selective inactivation of striatal FosB/ΔFosB-expressing neurons alleviates L-DOPA–induced dyskinesia M Engeln, MF Bastide, E Toulmé, B Dehay, M Bourdenx, E Doudnikoff, ... Biological psychiatry 79 (5), 354-361, 2016 | 92 | 2016 |
| Immediate-early gene expression in structures outside the basal ganglia is associated to l-DOPA-induced dyskinesia MF Bastide, S Dovero, G Charron, G Porras, CE Gross, PO Fernagut, ... Neurobiology of disease 62, 179-192, 2014 | 92 | 2014 |
| Spinal miRNA-124 regulates synaptopodin and nociception in an animal model of bone cancer pain S Elramah, MJ López-González, M Bastide, F Dixmérias, O Roca-Lapirot, ... Scientific reports 7 (1), 10949, 2017 | 45 | 2017 |
| Inhibiting lateral habenula improves L-DOPA–induced dyskinesia MF Bastide, B de La Crompe, E Doudnikoff, PO Fernagut, CE Gross, ... Biological psychiatry 79 (5), 345-353, 2016 | 21 | 2016 |
| Involvement of the bed nucleus of the stria terminalis in L-Dopa induced dyskinesia MF Bastide, C Glangetas, E Doudnikoff, Q Li, M Bourdenx, PO Fernagut, ... Scientific Reports 7 (1), 2348, 2017 | 8 | 2017 |
| Striatal NELF-mediated RNA polymerase II stalling controls l-dopa induced dyskinesia MF Bastide, S Bido, N Duteil, E Bézard Neurobiology of disease 85, 93-98, 2016 | 7 | 2016 |
| L-dopa induced dyskinesia in Parkinson's disease MF Bastide, E Bezard Bulletin de l'Academie nationale de medecine 199 (2-3), 201-212, 2015 | 7 | 2015 |
| Basal ganglia circuitry models of levodopa-induced dyskinesia WKD Ko, M Bastide, E Bezard Levodopa-Induced Dyskinesia in Parkinson's Disease, 109-134, 2014 | 3 | 2014 |
| Les dyskinésies L-dopa induites dans la maladie de Parkinson MF Bastide, E Bézard Bulletin de l'Académie Nationale de Médecine 199 (2-3), 201-212, 2015 | 1 | 2015 |
| Motor cortex acquires a pivotal role in levodopa-induced dyskinesia pathophysiology MF Bastide Movement disorders: official journal of the Movement Disorder Society 28 (13 …, 2013 | 1 | 2013 |
| Enhancement of lysosomal biogenesis reverse A53T mutant alpha-synuclein induced toxicity M Bourdenx, S Dovero, M Bastide, G Porras, N Dutheil, Q Li, A Ballabio, ... MOVEMENT DISORDERS 30 (14), 1985-1985, 2015 | | 2015 |
| Progressive nigrostriatal neurodegeneration associated with α-synuclein pathology induced by AAV-mediated overexpression of mutant α-synuclein in mice, rats and marmosets M Bourdenx, S Dovero, M Engeln, S Bido, C Piron, M Bastide, ... Movement Disorders 30, S32-S32, 2015 | | 2015 |
| Multifunctional approach of L-Dopa induced dyskinesia pathophysiology in Parkinson’s disease: from the striatum to the whole brain M Bastide Université de Bordeaux, 2014 | | 2014 |
| PSD-95 expression controls L-Dopa dyskinesia M Bastide, E Bézard Médecine/Sciences 29 (2), 139-41, 2013 | | 2013 |
